Pembrolizumab Approved for Children and Adults with Hard-to-Treat Hodgkin Lymphoma

From
March 15, 2017 - 12:30pm
Pembrolizumab is second anti-PD-1 drug approved for adults with cHL, first for any childhood cancer


Continue reading this article »